Sort   by:  
 Page size 
UnknownDaratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes.
Not available
S-EPMC11976258 | biostudies-literature
UnknownDaratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.
Not available
S-EPMC10045721 | biostudies-literature
UnknownGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Not available
S-EPMC3182531 | biostudies-literature
UnknownEfficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244 | biostudies-literature
Sort   by:  
 Page size